These data identify KDM4B and EHF as novel AR target genes in breast cancer cells and show that GATA3 co-regulates AR signaling in transcriptional regulation of these and likely other genes that promote a luminal epithelial phenotype in ER+ and ER- breast cancer contexts. This evidence concerns the gene KDM4B and breast cancer.